Delivery Order SPE2DB22D2206-SPE2DB25FJM90
- Not listed
- The Defense Logistics Agency awarded a $6,014.17 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Infuvite Adult Vial 10ml, a parenteral nutrition product. This is a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, and represents a child order under AmerisourceBergen's larger federal contract vehicle. The award was competitively awarded with no set-aside designation. Performance will occur at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $11,265.34 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Infuvite Adult Vial 10ml, a parenteral nutrition product used in clinical settings. This is a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $6,461.28 by the Defense Logistics Agency for Infuvite Adult Vial 10ML, a pharmaceutical product used in medical supply and healthcare delivery. This firm fixed price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by July 22, 2025. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,620.21 to AmerisourceBergen Drug Corp for the supply of Infuvite Adult Bulk Vial 100ML, a parenteral nutrition product. This competitively awarded, firm fixed price contract was issued on July 21, 2025, with an ultimate completion date of July 22, 2025, and involves performance at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Infuvite Adult Bulk Vial 100ML, a nutritional supplement product. This firm fixed-price delivery order, valued at $11,687.94, is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The contract was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $6,017.91 to AmerisourceBergen Drug Corp for Infuvite Adult Vial 10ML, a parenteral nutrition product used in clinical and military healthcare settings. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement with an ultimate completion date of August 26, 2025. The delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,435.68 to AmerisourceBergen Drug Corp for Infuvite Pediatric Bulk Vial 50ML, a pharmaceutical product for pediatric intravenous nutrition support. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 19, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $5,214.08 for Infuvite Adult 10ML (5 units) by the Defense Logistics Agency's Medical Supply Chain on August 14, 2025, with an ultimate completion date of August 15, 2025. The contract employs firm fixed-price pricing and was competitively awarded with no set-aside designation. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for INFUVITE ADULT VIAL 10ML, an intravenous nutritional supplement product, valued at $11.5K. This non-competitive, firm fixed-price delivery order was issued on August 25, 2025, with an ultimate completion date of August 26, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The order represents a child contract action under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $4,103.51 to AmerisourceBergen Drug Corp for Infuvite Pediatric Vial 5ML, a pediatric nutritional supplement product. The contract is a firm fixed-price delivery order with an ultimate completion date of September 5, 2025, and was competitively awarded without set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJM90Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $14,316.75 to AmerisourceBergen Drug Corp for Infuvite Adult Bulk Vial 100ML, a pharmaceutical product for medical supply support. The contract, awarded on August 20, 2025, carries a firm fixed price structure with an ultimate completion date of August 21, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location in Conshohocken, PA 19428. This delivery order operates as a child contract under AmerisourceBergen Drug Corp's significant Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.9 billion through December 2026. This prime contract vehicle provides comprehensive pharmaceutical and medical supply support to military healthcare programs globally, enabling the company to supply medications, vaccines, syringes, vials, and other critical medical commodities across multiple therapeutic domains. The arrangement reflects AmerisourceBergen Drug Corp's established role as a key federal pharmaceutical distributor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through a flexible contracting mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.3k | 8/20/25 |